FDA
approval
· 2022-02-07
FDA Approved: CABENUVA — Supplemental Application (ViiV Healthcare Company)
Summary
The FDA approved a supplemental application for CABENUVA (cabotegravir and rilpivirine) from ViiV Healthcare Company, resulting in changes to the product labeli…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CABENUVA (CABOTEGRAVIR AND RILPIVIRINE)